Literature DB >> 2291485

Fast atom bombardment mass spectrometric quantitative analysis of methionine-enkephalin in human pituitary tissues.

J J Kusmierz1, R Sumrada, D M Desiderio.   

Abstract

Picomole amounts of endogenous methionine-enkephalin (ME = YGGFM) were quantified in 11 individual human pituitaries by fast atom bombardment mass spectrometry methods. Quantification was based either upon the comparison of the molecular ion (MH+) current of endogenous ME versus the current of a deuterated ME internal standard (d5-ME) or, similarly, upon the unimolecular decomposition MH+----YGGF-+ In the first field-free region to produce the unique tetrapeptide fragment ion. The latter method used the multiple reaction monitoring (MRM) mode. Native ME was purified with an octadecylsilyl (ODS) disposable cartridge and with multidimensional reversed-phase high-performance liquid chromatography. The amounts of ME determined were 18.26 +/- 19.98 ng of ME/mg of protein with the MH+ method and 15.28 +/- 16.59 ng of ME/mg of protein with the MRM method. A fraction (ca. 4%) of the total amount of ME from one pituitary was used to acquire these quantitative data, and ca. half of the remaining amount of a separate sample (no d5-ME added) was used to obtain a linked scan at constant B/E (B, magnetic field; E, electric field) of the ME MH+ at 574 u to produce the amino acid sequence determining fragment ions at m/z 297, 354, 411, 397, 278, and 425 u corresponding to Y2", Y3", Y4", A4, B3, and B4, respectively. That product ion spectrum was similar to a scan of 100 ng of synthetic ME. We calculated that the amount of pentapeptide for the MRM experiments corresponded to a total of 30 ng (52 pmol) of ME on the probe tip during quantification. On the other hand, we estimated that 3 times more, or 90 ng (156 pmol), ME was on the probe tip during acquisition of the product ion spectrum.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2291485     DOI: 10.1021/ac00220a026

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  11 in total

1.  Electrospray mass spectrometry for the analysis of opioid peptides and for the quantification of endogenous methionine enkephalin and β-endorphin.

Authors:  C Dass; J J Kusmierz; D M Desiderio; S A Jarvis; B N Green
Journal:  J Am Soc Mass Spectrom       Date:  1991-04       Impact factor: 3.109

2.  Micro-electrospray mass spectrometry: Ultra-high-sensitivity analysis of peptides and proteins.

Authors:  M R Emmett; R M Caprioli
Journal:  J Am Soc Mass Spectrom       Date:  1994-07       Impact factor: 3.109

3.  Matrix-assisted laser desorption mass spectrometry of biotransformation products of dynorphin a in vitro.

Authors:  J Z Chou; M J Kreek; B T Chait
Journal:  J Am Soc Mass Spectrom       Date:  1994-01       Impact factor: 3.109

4.  Monitoring a nuclear factor-κB signature of drug resistance in multiple myeloma.

Authors:  Yun Xiang; Elizabeth R Remily-Wood; Vasco Oliveira; Danielle Yarde; Lili He; Jin Q Cheng; Linda Mathews; Kelly Boucher; Christopher Cubitt; Lia Perez; Ted J Gauthier; Steven A Eschrich; Kenneth H Shain; William S Dalton; Lori Hazlehurst; John M Koomen
Journal:  Mol Cell Proteomics       Date:  2011-08-16       Impact factor: 5.911

Review 5.  Recent advances in quantitative neuroproteomics.

Authors:  George E Craft; Anshu Chen; Angus C Nairn
Journal:  Methods       Date:  2013-04-25       Impact factor: 3.608

6.  Relative quantitation of neuropeptides over a thousand-fold concentration range.

Authors:  Xiaowen Hou; Fang Xie; Jonathan V Sweedler
Journal:  J Am Soc Mass Spectrom       Date:  2012-09-20       Impact factor: 3.109

Review 7.  Quantitation of endogenous peptides using mass spectrometry based methods.

Authors:  Elena V Romanova; Sarah E Dowd; Jonathan V Sweedler
Journal:  Curr Opin Chem Biol       Date:  2013-06-18       Impact factor: 8.822

8.  Characterization of an opioid peptide-containing protein and of bovine α-lactalbumin by electrospray ionization and liquid secondary ion mass spectrometry.

Authors:  L Yan; J L Tseng; G H Fridland; D M Desiderio
Journal:  J Am Soc Mass Spectrom       Date:  1994-05       Impact factor: 3.109

Review 9.  Using quantitative proteomic analysis to understand genotype specific intrinsic drug resistance in melanoma.

Authors:  John M Koomen; Keiran S M Smalley
Journal:  Oncotarget       Date:  2011-04

10.  Mass spectrometry-based approaches toward absolute quantitative proteomics.

Authors:  Keiji Kito; Takashi Ito
Journal:  Curr Genomics       Date:  2008-06       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.